nodes	percent_of_prediction	percent_of_DWPC	metapath
Nandrolone decanoate—Azoospermia—Cisplatin—bone cancer	0.0588	0.0921	CcSEcCtD
Nandrolone decanoate—Oligospermia—Methotrexate—bone cancer	0.0415	0.065	CcSEcCtD
Nandrolone decanoate—Oligospermia—Epirubicin—bone cancer	0.0388	0.0608	CcSEcCtD
Nandrolone decanoate—Oligospermia—Doxorubicin—bone cancer	0.0359	0.0563	CcSEcCtD
Nandrolone decanoate—Azoospermia—Methotrexate—bone cancer	0.0323	0.0505	CcSEcCtD
Nandrolone decanoate—Estradiol valerate/Dienogest—CYP3A4—bone cancer	0.031	0.455	CrCbGaD
Nandrolone decanoate—Azoospermia—Epirubicin—bone cancer	0.0302	0.0473	CcSEcCtD
Nandrolone decanoate—Azoospermia—Doxorubicin—bone cancer	0.028	0.0438	CcSEcCtD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.0242	0.0826	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Methotrexate—bone cancer	0.0205	0.032	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—T—bone cancer	0.0193	0.0657	CbGpPWpGaD
Nandrolone decanoate—Furunculosis—Epirubicin—bone cancer	0.0191	0.03	CcSEcCtD
Nandrolone decanoate—Furuncle—Methotrexate—bone cancer	0.0177	0.0278	CcSEcCtD
Nandrolone decanoate—Furunculosis—Doxorubicin—bone cancer	0.0177	0.0277	CcSEcCtD
Nandrolone decanoate—Furuncle—Epirubicin—bone cancer	0.0166	0.026	CcSEcCtD
Nandrolone decanoate—Furuncle—Doxorubicin—bone cancer	0.0154	0.024	CcSEcCtD
Nandrolone decanoate—Fluid retention—Cisplatin—bone cancer	0.015	0.0236	CcSEcCtD
Nandrolone decanoate—Local reaction—Epirubicin—bone cancer	0.0147	0.023	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptors—NR1I2—bone cancer	0.0139	0.0474	CbGpPWpGaD
Nandrolone decanoate—Local reaction—Doxorubicin—bone cancer	0.0136	0.0213	CcSEcCtD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—FEV—bone cancer	0.0133	0.0453	CbGpPWpGaD
Nandrolone decanoate—Etonogestrel—CYP3A4—bone cancer	0.0127	0.186	CrCbGaD
Nandrolone decanoate—Seborrhoeic dermatitis—Epirubicin—bone cancer	0.0119	0.0187	CcSEcCtD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—FEV—bone cancer	0.0117	0.0399	CbGpPWpGaD
Nandrolone decanoate—Hyperlipidaemia—Epirubicin—bone cancer	0.0113	0.0177	CcSEcCtD
Nandrolone decanoate—Seborrhoeic dermatitis—Doxorubicin—bone cancer	0.011	0.0173	CcSEcCtD
Nandrolone decanoate—AR—Nuclear Receptor transcription pathway—NR1I2—bone cancer	0.011	0.0375	CbGpPWpGaD
Nandrolone decanoate—Irritability—Cisplatin—bone cancer	0.011	0.0172	CcSEcCtD
Nandrolone decanoate—Hyperlipidaemia—Doxorubicin—bone cancer	0.0104	0.0164	CcSEcCtD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP4V2—bone cancer	0.0104	0.0355	CbGpPWpGaD
Nandrolone decanoate—Dysphonia—Epirubicin—bone cancer	0.00989	0.0155	CcSEcCtD
Nandrolone decanoate—MAOB—Tryptophan metabolism—CYP3A4—bone cancer	0.0098	0.0334	CbGpPWpGaD
Nandrolone decanoate—Amenorrhoea—Epirubicin—bone cancer	0.00926	0.0145	CcSEcCtD
Nandrolone decanoate—Dysphonia—Doxorubicin—bone cancer	0.00915	0.0143	CcSEcCtD
Nandrolone decanoate—Levonorgestrel—CYP3A4—bone cancer	0.00899	0.132	CrCbGaD
Nandrolone decanoate—Amenorrhoea—Doxorubicin—bone cancer	0.00857	0.0134	CcSEcCtD
Nandrolone decanoate—Gynaecomastia—Methotrexate—bone cancer	0.00778	0.0122	CcSEcCtD
Nandrolone decanoate—Fluid retention—Epirubicin—bone cancer	0.00772	0.0121	CcSEcCtD
Nandrolone decanoate—Norethindrone—CYP3A4—bone cancer	0.00729	0.107	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Cisplatin—bone cancer	0.00717	0.0112	CcSEcCtD
Nandrolone decanoate—Fluid retention—Doxorubicin—bone cancer	0.00715	0.0112	CcSEcCtD
Nandrolone decanoate—Hepatic function abnormal—Epirubicin—bone cancer	0.00676	0.0106	CcSEcCtD
Nandrolone decanoate—MAOB—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00642	0.0219	CbGpPWpGaD
Nandrolone decanoate—Hepatic function abnormal—Doxorubicin—bone cancer	0.00625	0.00979	CcSEcCtD
Nandrolone decanoate—Irritability—Methotrexate—bone cancer	0.00602	0.00943	CcSEcCtD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—CYP3A4—bone cancer	0.006	0.0205	CbGpPWpGaD
Nandrolone decanoate—Oedema—Cisplatin—bone cancer	0.00565	0.00885	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—ZNF77—bone cancer	0.00561	0.0191	CbGpPWpGaD
Nandrolone decanoate—Erectile dysfunction—Methotrexate—bone cancer	0.00502	0.00787	CcSEcCtD
Nandrolone decanoate—CYP19A1—Ovarian Infertility Genes—CDK4—bone cancer	0.00497	0.017	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00485	0.0165	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.00479	0.0163	CbGpPWpGaD
Nandrolone decanoate—MAOB—Tryptophan metabolism—MDM2—bone cancer	0.0045	0.0154	CbGpPWpGaD
Nandrolone decanoate—Jaundice—Epirubicin—bone cancer	0.00444	0.00695	CcSEcCtD
Nandrolone decanoate—Progesterone—CYP3A4—bone cancer	0.00425	0.0622	CrCbGaD
Nandrolone decanoate—Jaundice—Doxorubicin—bone cancer	0.00411	0.00643	CcSEcCtD
Nandrolone decanoate—MAOA—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00403	0.0138	CbGpPWpGaD
Nandrolone decanoate—Testosterone—CYP3A4—bone cancer	0.00401	0.0588	CrCbGaD
Nandrolone decanoate—Mediastinal disorder—Methotrexate—bone cancer	0.00393	0.00616	CcSEcCtD
Nandrolone decanoate—CYP19A1—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00393	0.0134	CbGpPWpGaD
Nandrolone decanoate—AR—Notch-mediated HES/HEY network—RB1—bone cancer	0.00369	0.0126	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Epirubicin—bone cancer	0.00368	0.00577	CcSEcCtD
Nandrolone decanoate—Rash—Cisplatin—bone cancer	0.00356	0.00558	CcSEcCtD
Nandrolone decanoate—Dermatitis—Cisplatin—bone cancer	0.00356	0.00558	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—CYP3A4—bone cancer	0.00341	0.0116	CbGpPWpGaD
Nandrolone decanoate—Mediastinal disorder—Doxorubicin—bone cancer	0.00341	0.00533	CcSEcCtD
Nandrolone decanoate—Nausea—Cisplatin—bone cancer	0.00336	0.00526	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.00317	0.0108	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Epirubicin—bone cancer	0.00307	0.00481	CcSEcCtD
Nandrolone decanoate—MAOB—Biological oxidations—GSTP1—bone cancer	0.00292	0.00996	CbGpPWpGaD
Nandrolone decanoate—Oedema—Epirubicin—bone cancer	0.0029	0.00455	CcSEcCtD
Nandrolone decanoate—AR—FOXA1 transcription factor network—JUN—bone cancer	0.00289	0.00985	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.00286	0.00976	CbGpPWpGaD
Nandrolone decanoate—Hypertension—Doxorubicin—bone cancer	0.00284	0.00445	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.00276	0.00943	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Tryptophan metabolism—MDM2—bone cancer	0.00276	0.00941	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.00275	0.00938	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—ZNF77—bone cancer	0.0027	0.00921	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.00269	0.00919	CbGpPWpGaD
Nandrolone decanoate—Oedema—Doxorubicin—bone cancer	0.00269	0.00421	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.00266	0.00907	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.00249	0.00849	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Methotrexate—bone cancer	0.00246	0.00386	CcSEcCtD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.00245	0.00836	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.00238	0.00811	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.00232	0.0079	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Epirubicin—bone cancer	0.00231	0.00361	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.0023	0.00786	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.00229	0.0078	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.00225	0.00768	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.00223	0.00762	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.00222	0.00756	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.0022	0.00751	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Methotrexate—bone cancer	0.00219	0.00344	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—CYP3A4—bone cancer	0.00214	0.00731	CbGpPWpGaD
Nandrolone decanoate—Urticaria—Doxorubicin—bone cancer	0.00213	0.00334	CcSEcCtD
Nandrolone decanoate—CYP19A1—Biological oxidations—CYP3A4—bone cancer	0.00209	0.00713	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—CYP3A4—bone cancer	0.00206	0.00703	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Epirubicin—bone cancer	0.00205	0.00322	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—NDUFA12—bone cancer	0.00205	0.00698	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.00198	0.00676	CbGpPWpGaD
Nandrolone decanoate—Rash—Methotrexate—bone cancer	0.00196	0.00306	CcSEcCtD
Nandrolone decanoate—Dermatitis—Methotrexate—bone cancer	0.00195	0.00306	CcSEcCtD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.00194	0.00661	CbGpPWpGaD
Nandrolone decanoate—Pruritus—Doxorubicin—bone cancer	0.0019	0.00298	CcSEcCtD
Nandrolone decanoate—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.0019	0.00648	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.00189	0.00645	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00187	0.00637	CbGpPWpGaD
Nandrolone decanoate—Nausea—Methotrexate—bone cancer	0.00184	0.00288	CcSEcCtD
Nandrolone decanoate—MAOA—Biological oxidations—GSTP1—bone cancer	0.00183	0.00625	CbGpPWpGaD
Nandrolone decanoate—Rash—Epirubicin—bone cancer	0.00183	0.00287	CcSEcCtD
Nandrolone decanoate—Dermatitis—Epirubicin—bone cancer	0.00183	0.00286	CcSEcCtD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.00179	0.0061	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Biological oxidations—GSTP1—bone cancer	0.00179	0.0061	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.00177	0.00604	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metapathway biotransformation—GSTP1—bone cancer	0.00176	0.00601	CbGpPWpGaD
Nandrolone decanoate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.00174	0.00594	CbGpPWpGaD
Nandrolone decanoate—Nausea—Epirubicin—bone cancer	0.00172	0.0027	CcSEcCtD
Nandrolone decanoate—MAOB—Metabolism—NT5C3A—bone cancer	0.00169	0.00578	CbGpPWpGaD
Nandrolone decanoate—Rash—Doxorubicin—bone cancer	0.00169	0.00265	CcSEcCtD
Nandrolone decanoate—Dermatitis—Doxorubicin—bone cancer	0.00169	0.00265	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.00167	0.0057	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.00164	0.00561	CbGpPWpGaD
Nandrolone decanoate—Nausea—Doxorubicin—bone cancer	0.0016	0.0025	CcSEcCtD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.00148	0.00504	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.00145	0.00495	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.00144	0.0049	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00138	0.00472	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—FUS—bone cancer	0.00132	0.0045	CbGpPWpGaD
Nandrolone decanoate—AR—Androgen receptor signaling pathway—EGFR—bone cancer	0.00129	0.00441	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NDUFA12—bone cancer	0.00128	0.00438	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.00127	0.00434	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NDUFA12—bone cancer	0.00125	0.00427	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—RB1—bone cancer	0.00125	0.00426	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00124	0.00422	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	0.00108	0.00367	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00107	0.00364	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—NT5C3A—bone cancer	0.00106	0.00363	CbGpPWpGaD
Nandrolone decanoate—AR—SIDS Susceptibility Pathways—JUN—bone cancer	0.00105	0.00358	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—BRAF—bone cancer	0.00104	0.00355	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—NT5C3A—bone cancer	0.00104	0.00354	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.00103	0.0035	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000989	0.00337	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—JUN—bone cancer	0.000926	0.00316	CbGpPWpGaD
Nandrolone decanoate—MAOA—SIDS Susceptibility Pathways—JUN—bone cancer	0.000925	0.00316	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—NR1I2—bone cancer	0.000914	0.00312	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000892	0.00304	CbGpPWpGaD
Nandrolone decanoate—MAOA—Transmission across Chemical Synapses—MDM2—bone cancer	0.000872	0.00298	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000846	0.00289	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—BRAF—bone cancer	0.000798	0.00272	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—ENO2—bone cancer	0.000742	0.00253	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—EGFR—bone cancer	0.000728	0.00248	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	0.00071	0.00242	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000701	0.00239	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—DHFR—bone cancer	0.000689	0.00235	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EIF2S1—bone cancer	0.000675	0.0023	CbGpPWpGaD
Nandrolone decanoate—MAOA—Neuronal System—MDM2—bone cancer	0.000668	0.00228	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GNA11—bone cancer	0.000644	0.0022	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Integrated Breast Cancer Pathway—TP53—bone cancer	0.000611	0.00209	CbGpPWpGaD
Nandrolone decanoate—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000589	0.00201	CbGpPWpGaD
Nandrolone decanoate—AR—Gene Expression—EZH2—bone cancer	0.000586	0.002	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—CYP3A4—bone cancer	0.000584	0.00199	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—GSTP1—bone cancer	0.000499	0.0017	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—ENO2—bone cancer	0.000466	0.00159	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—ENO2—bone cancer	0.000454	0.00155	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—DHFR—bone cancer	0.000432	0.00147	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—DHFR—bone cancer	0.000421	0.00144	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GNA11—bone cancer	0.000404	0.00138	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GNA11—bone cancer	0.000394	0.00134	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—CYP3A4—bone cancer	0.000366	0.00125	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—CYP3A4—bone cancer	0.000357	0.00122	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000355	0.00121	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—GSTP1—bone cancer	0.000313	0.00107	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—GSTP1—bone cancer	0.000305	0.00104	CbGpPWpGaD
Nandrolone decanoate—MAOB—Metabolism—PTGS2—bone cancer	0.000259	0.000882	CbGpPWpGaD
Nandrolone decanoate—MAOA—Metabolism—PTGS2—bone cancer	0.000162	0.000554	CbGpPWpGaD
Nandrolone decanoate—CYP19A1—Metabolism—PTGS2—bone cancer	0.000158	0.00054	CbGpPWpGaD
